CGRP agonist peptides
US9951115B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Inventor
Key dates
| Filing date | Jul 29, 2014 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Jul 29, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The embodiments provide a calcitonin gene-related peptide (CGRP) agonist peptide or pharmaceutically acceptable salt thereof, including pharmaceutical compositions comprising a CGRP agonist peptide. The embodiments further provide treatment methods, including method of treating metabolic disorders and metabolic disorders selected from metabolic syndrome, diabetes and obesity. The methods involve administering to a subject in need thereof an effective amount of CGRP peptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.